Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Vomiting 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Seminoma 1Nausea 1

Interventions

Etoposide 4Cisplatin 4Ifosfamide 3Filgrastim 3Carboplatin 3Bleomycin 3pegfilgrastim 2Paclitaxel 2lerisetron 1isophosphamide mustard 1Watchful Waiting 1Vinblastine 1Surveys and Questionnaires 1Sorafenib 1Radiotherapy 1Polymerase Chain Reaction 1Peripheral Blood Stem Cell Transplantation 1Olanzapine 1Magnetic Resonance Spectroscopy 1Lenograstim 1Granisetron 1Gemcitabine 1Flow Cytometry 1Drug Therapy 1Dexamethasone 1Chemotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Testicular Neoplasms × lerisetron × Clear all
NCT00004219 2013-08-02

Lerisetron Compared With Granisetron in Preventing Nausea and Vomiting in Men Being Treated With Radiation Therapy for Stage I Seminoma

National Cancer Institute (NCI)

Phase 3 Unknown
150 enrolled
Genitourinary

Testicular Germ Cell Tumor, Nausea, Testicular Neoplasms, Vomiting, Seminoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡